vx 497 has been researched along with alprenolol in 1 studies
Studies (vx 497) | Trials (vx 497) | Recent Studies (post-2010) (vx 497) | Studies (alprenolol) | Trials (alprenolol) | Recent Studies (post-2010) (alprenolol) |
---|---|---|---|---|---|
25 | 3 | 7 | 1,146 | 121 | 59 |
Protein | Taxonomy | vx 497 (IC50) | alprenolol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0031 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.007 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.63 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 0.0023 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0049 | |
Squalene synthase | Rattus norvegicus (Norway rat) | 4.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for vx 497 and alprenolol
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |